Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma
- PMID: 16410791
- DOI: 10.1038/sj.jid.5700083
Kaposi's sarcoma-associated herpesvirus viremia is associated with the progression of classic and endemic Kaposi's sarcoma
Abstract
In order to gain further insight on the role of Kaposi's sarcoma-associated herpesvirus (KSHV) in classic and endemic Kaposi's sarcoma (KS) pathogenesis, we aimed to determine (i) whether KSHV is detectable in peripheral blood mononuclear cells (PBMCs), (ii) which PBMCs subpopulation harbor the virus, (iii) which clinical, histologic, and immunologic parameters are associated with KSHV viremia in a population of classic and endemic KS. KSHV viremia and various immunologic parameters were screened on 81 patients. KSHV viremia was positive in 58% of the patients. KSHV was detected in B cells, T cells, and monocytes. CD34+ cells depleted in circulating endothelial cells (CECs) were never infected and 50% of the patients tested had CECs infected by KSHV. We observed a significant increase of IL-2 and IFN-gamma production by CD4 T cells and an increase of IFN-gamma production by CD8 T cells compared to control patients. KS progression (P = 0.001) and KS staging (P = 0.03) were significantly and independently associated with positive KSHV viremia. Our results show that there is no specific immunosuppression in classic or endemic KS. We showed that KSHV can be detected within CECs and that KSHV viremia could be an indicator of circulating mature or precursor spindle cells.
Comment in
-
Looking for the target cell of Kaposi's sarcoma-associated herpesvirus.J Invest Dermatol. 2006 Mar;126(3):545-7. doi: 10.1038/sj.jid.5700132. J Invest Dermatol. 2006. PMID: 16482196
Similar articles
-
Looking for the target cell of Kaposi's sarcoma-associated herpesvirus.J Invest Dermatol. 2006 Mar;126(3):545-7. doi: 10.1038/sj.jid.5700132. J Invest Dermatol. 2006. PMID: 16482196
-
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.AIDS. 2007 Jun 19;21(10):1245-52. doi: 10.1097/QAD.0b013e328182df03. AIDS. 2007. PMID: 17545700 Clinical Trial.
-
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.AIDS. 2003 Aug 15;17(12):1847-51. doi: 10.1097/00002030-200308150-00015. AIDS. 2003. PMID: 12891072
-
The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases.Ann Oncol. 1997;8 Suppl 2:123-9. Ann Oncol. 1997. PMID: 9209655 Review.
-
Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS.Infect Agents Dis. 1996 Oct;5(4):215-22. Infect Agents Dis. 1996. PMID: 8884366 Review.
Cited by
-
Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a.Oncogene. 2010 Mar 25;29(12):1835-44. doi: 10.1038/onc.2009.460. Epub 2009 Dec 21. Oncogene. 2010. PMID: 20023696 Free PMC article.
-
Kaposi Sarcoma in a Non HIV Patient.Int J Health Sci (Qassim). 2008 Jul;2(2):153-6. Int J Health Sci (Qassim). 2008. PMID: 21475497 Free PMC article.
-
Solitary incidental primary Kaposi's sarcoma of the glans penis in a patient with no risk factors.Urol Ann. 2020 Jul-Sep;12(3):283-285. doi: 10.4103/UA.UA_172_19. Epub 2020 Jul 17. Urol Ann. 2020. PMID: 33100756 Free PMC article.
-
Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus.PLoS One. 2008 Jan 30;3(1):e1520. doi: 10.1371/journal.pone.0001520. PLoS One. 2008. PMID: 18231605 Free PMC article.
-
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation.Adv Virol. 2011;2011:193860. doi: 10.1155/2011/193860. Adv Virol. 2011. PMID: 21625290 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials